Filing Details

Accession Number:
0001209191-21-033813
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-05-18 20:17:44
Reporting Period:
2021-05-14
Accepted Time:
2021-05-18 20:17:44
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1796280 Oric Pharmaceuticals Inc. ORIC () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1608936 Jacob Chacko C/O Oric Pharmaceuticals, Inc.
240 E. Grand Ave., 2Nd Floor
South San Francisco CA 94080
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-05-14 13,896 $25.36 44,284 No 4 S Direct
Common Stock Disposition 2021-05-17 2,550 $25.05 41,734 No 4 S Direct
Common Stock Disposition 2021-05-18 11,132 $25.37 30,602 No 4 S Direct
Common Stock Disposition 2021-05-18 200 $26.03 30,402 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  2. Represents the weighted average share price of an aggregate total of 13,896 shares sold in the price range of $25.00 to $25.85 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  3. Represents the weighted average share price of an aggregate total of 2,550 shares sold in the price range of $25.00 to $25.27 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  4. Represents the weighted average share price of an aggregate total of 11,132 shares sold in the price range of $25.00 to $25.93 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.